Lars M. Videbaek - Publications

Associations of body mass index on worsening of heart failure and mortality in patients with heart failure and reduced left ventricular ejection fraction: a 10-year follow-up study (a NorthStar substudy).

Journal: Cardiovascular diabetology

Published: August 24, 2025

Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Analysis of DANISH.

Journal: Journal of the American College of Cardiology

Published: August 12, 2025

Implantable Cardioverter-Defibrillator and Frailty in Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up of the DANISH Trial.

Journal: The American journal of cardiology

Published: August 05, 2025

Effects of empagliflozin on right ventricular free-wall strain in patients with heart failure and reduced ejection fraction: results from the Empire HF Trial.

Journal: ESC heart failure

Published: July 29, 2025

Atrial fibrillation and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: insights from the DANISH trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: July 03, 2025

Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2025

Left Ventricular Ejection Fraction and Implantable Cardioverter Defibrillator in Nonischemic Heart Failure With Reduced Ejection Fraction: Insights From DANISH.

Journal: Circulation

Published: December 10, 2024

Anthropometric measures and long-term mortality in non-ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradox.

Journal: European journal of heart failure

Published: June 20, 2024

Excess long-term risk of adverse outcomes in heart failure patients with high and low levels of NT-proBNP: A 7-year follow-up study (NorthStar Trial).

Journal: International journal of cardiology. Heart & vasculature

Published: March 24, 2024

Estimated Glomerular Filtration Rate and Implantable Cardioverter-Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow-Up of DANISH.

Journal: Journal of the American Heart Association

Published: January 31, 2024

Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.

Journal: International journal of cardiology

Published: October 09, 2023

Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.

Journal: Circulation

Published: October 09, 2023